e-Article
Centrally determined PD-L1 among non-eligible for cisplatin-based chemotherapy recurrent/metastatic head and neck patients (R/M HNSCC pts): Pathology outcomes from the NIVOTAX trial.
Document Type
Journal
Author
Iglesias, Lara; Belen Enguita, Ana; Yarza, Ramon; Duran, Marisa; Jimenez Almonacid, Justino; Baste, Neus; Carral Maseda, Alberto; Oliva, Marc; Perez Segura, Pedro; Medina-Colmenero, Ana; Cirauqui, Beatriz; Arrazubi, Virginia; Gutierrez Calderon, Vanesa; Martinez-Trufero, Javier; del Barco Morillo, Edel; Garcia Castano, Almudena; Rubio-Casadevall, Jordi; Basterretxea, Laura; Brana, Irene; Mesia, Ricard
Source
Subject
Language
English
ISSN
15277755